JP2018511303A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018511303A5 JP2018511303A5 JP2017541701A JP2017541701A JP2018511303A5 JP 2018511303 A5 JP2018511303 A5 JP 2018511303A5 JP 2017541701 A JP2017541701 A JP 2017541701A JP 2017541701 A JP2017541701 A JP 2017541701A JP 2018511303 A5 JP2018511303 A5 JP 2018511303A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- salmonella
- antibody fragment
- seq
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 23
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 23
- 238000000034 method Methods 0.000 claims 17
- 241001465754 Metazoa Species 0.000 claims 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims 16
- 241000607142 Salmonella Species 0.000 claims 14
- 241000287828 Gallus gallus Species 0.000 claims 5
- 206010039438 Salmonella Infections Diseases 0.000 claims 5
- 206010039447 salmonellosis Diseases 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 241001515965 unidentified phage Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 108010062877 Bacteriocins Proteins 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 101001114134 Gloydius halys Neutral phospholipase A2 agkistrodotoxin Proteins 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 108090000284 Pepsin A Proteins 0.000 claims 1
- 102000057297 Pepsin A Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 102000038379 digestive enzymes Human genes 0.000 claims 1
- 108091007734 digestive enzymes Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002550 fecal effect Effects 0.000 claims 1
- 210000003495 flagella Anatomy 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940111202 pepsin Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 230000000529 probiotic effect Effects 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- 229960001322 trypsin Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562112035P | 2015-02-04 | 2015-02-04 | |
| US62/112,035 | 2015-02-04 | ||
| PCT/IB2016/050546 WO2016125089A1 (en) | 2015-02-04 | 2016-02-03 | Anti-salmonella antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020068020A Division JP2020120667A (ja) | 2015-02-04 | 2020-04-06 | 抗サルモネラ抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018511303A JP2018511303A (ja) | 2018-04-26 |
| JP2018511303A5 true JP2018511303A5 (cg-RX-API-DMAC7.html) | 2019-03-07 |
Family
ID=56563529
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017541701A Pending JP2018511303A (ja) | 2015-02-04 | 2016-02-03 | 抗サルモネラ抗体及びその使用 |
| JP2020068020A Pending JP2020120667A (ja) | 2015-02-04 | 2020-04-06 | 抗サルモネラ抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020068020A Pending JP2020120667A (ja) | 2015-02-04 | 2020-04-06 | 抗サルモネラ抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10421806B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3253789A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2018511303A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016214059B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2972568A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016125089A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3440208B1 (en) | 2016-04-06 | 2020-09-16 | Zumutor Biologics, Inc. | Vectors for cloning and expression of proteins, methods and applications thereof |
| AU2019215440B2 (en) | 2018-02-05 | 2025-12-04 | Orionis Biosciences, Inc. | Fibroblast binding agents and use thereof |
| KR20220160670A (ko) * | 2020-03-31 | 2022-12-06 | 바이오세우스 인크. | 항 pd-l1 및 pd-l2 항체 및 이의 유도체 및 용도 |
| CN112707963A (zh) * | 2021-01-26 | 2021-04-27 | 西北农林科技大学 | 广谱识别沙门氏菌的纳米抗体、重组载体、宿主细胞及其应用 |
| WO2025111553A2 (en) * | 2023-11-22 | 2025-05-30 | The General Hospital Corporation | Antibody-based human lamp-1 composition and its uses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0915158A3 (en) * | 1997-11-04 | 1999-10-20 | Unilever N.V. | Improvements in or relating to detection of salmonella |
| US20100239583A1 (en) * | 2009-03-04 | 2010-09-23 | Inotek Pharmaceuticals Corporation | Antibodies against flagellin and uses thereof |
| WO2012100343A1 (en) * | 2011-01-28 | 2012-08-02 | National Research Council Of Canada | Engineering of immunoglobulin domains |
| CN107074934B (zh) * | 2014-03-27 | 2021-06-29 | 萨姆巴德哈·高什 | 在乳杆菌中表达针对沙门氏菌的单链抗体 |
-
2016
- 2016-02-03 US US15/548,759 patent/US10421806B2/en not_active Expired - Fee Related
- 2016-02-03 WO PCT/IB2016/050546 patent/WO2016125089A1/en not_active Ceased
- 2016-02-03 CA CA2972568A patent/CA2972568A1/en not_active Abandoned
- 2016-02-03 AU AU2016214059A patent/AU2016214059B2/en not_active Ceased
- 2016-02-03 EP EP16746205.0A patent/EP3253789A4/en not_active Withdrawn
- 2016-02-03 JP JP2017541701A patent/JP2018511303A/ja active Pending
-
2019
- 2019-08-09 US US16/537,464 patent/US20200040067A1/en not_active Abandoned
-
2020
- 2020-04-06 JP JP2020068020A patent/JP2020120667A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shoaib et al. | MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework | |
| Stevens et al. | Molecular insights into farm animal and zoonotic Salmonella infections | |
| Molloy et al. | Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis | |
| Kober et al. | Immunomodulatory effects of probiotics: a novel preventive approach for the control of bovine mastitis | |
| Liu et al. | Dynamic changes in rumen fermentation and bacterial community following rumen fluid transplantation in a sheep model of rumen acidosis: implications for rumen health in ruminants | |
| Riazi et al. | Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickens | |
| Sponseller et al. | Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection | |
| JP2018511303A5 (cg-RX-API-DMAC7.html) | ||
| US20200040067A1 (en) | Anti-salmonella antibodies and uses thereof | |
| Cheung et al. | Virulence mechanisms of staphylococcal animal pathogens | |
| Kabir et al. | Antimicrobial Resistance in Equines: A Growing Threat to Horse Health and Beyond—A Comprehensive Review | |
| JP2010013454A (ja) | グラム陽性細菌のペプチドグリカンに対する多機能性モノクローナル抗体 | |
| Giau et al. | Recent advances in the treatment of C. difficile using biotherapeutic agents | |
| Heinzinger et al. | Evaluating the translational potential of bacteriocins as an alternative treatment for Staphylococcus aureus infections in animals and humans | |
| Karyal et al. | Colonisation factor CD0873, an attractive oral vaccine candidate against Clostridioides difficile | |
| Furlan et al. | Induced expression of cathelicidins in trout (Oncorhynchus mykiss) challenged with four different bacterial pathogens | |
| Garvey | Foodborne Clostridioides Species: Pathogenicity, Virulence and Biocontrol Options | |
| Lin et al. | Histophilus somni stimulates expression of antiviral proteins and inhibits BRSV replication in bovine respiratory epithelial cells | |
| CN104797597A (zh) | 针对胞壁肽的单克隆抗体 | |
| US10160803B2 (en) | Angiopoietin-related protein 4 (cAngptl4) as a diagnostic biomarker for acute lung damage | |
| JP2018512174A5 (cg-RX-API-DMAC7.html) | ||
| RU2009113831A (ru) | Ipad-белок шигеллы и его применение в качестве вакцины против шигеллезных инфекций | |
| Jonsson et al. | A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases | |
| Zhao et al. | Current trends in approaches to prevent and control antimicrobial resistance in aquatic veterinary medicine | |
| Punyokun et al. | The production of anti-Vibrio harveyi egg yolk immunoglobulin and evaluation of its stability and neutralisation efficacy |